Page last updated: 2024-08-24

plerixafor and tc14012

plerixafor has been researched along with tc14012 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baraz, R; Bendall, LJ; Bradstock, KF; Dela Pena, A; Juarez, JG; Thien, M1
Berchiche, YA; Boulais, PE; Fujii, N; Gravel, S; Heveker, N; Leduc, R; Malouf, C; Oishi, S; Sinnett, D1
Baraz, R; Bendall, LJ; Bradstock, KF; DiPersio, JF; Harun, N; Juarez, JG; Pena, AD; Pitson, SM; Rettig, M; Thien, M; Welschinger, R1
Bach, HH; Byron, KL; Gamelli, RL; Majetschak, M; Nevins, AM; Tripathi, A; Volkman, BF; Wong, YM1
Ge, B; He, H; Huang, F; Lao, J; Song, Y; Ullahkhan, N; Wang, X; Wang, Z; Yang, B1

Other Studies

5 other study(ies) available for plerixafor and tc14012

ArticleYear
CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK.
    British journal of haematology, 2009, Volume: 145, Issue:4

    Topics: Animals; B-Lymphocytes; Benzylamines; Bone Marrow; Cell Line, Tumor; Chemokine CXCL12; Chemotaxis, Leukocyte; Chromones; Cyclams; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Heterocyclic Compounds; Humans; Imidazoles; Mice; Mice, Inbred NOD; Mice, SCID; Morpholines; Neoplastic Stem Cells; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Phosphoinositide-3 Kinase Inhibitors; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Receptors, CXCR4

2009
The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.
    The Journal of biological chemistry, 2010, Dec-03, Volume: 285, Issue:49

    Topics: Anti-HIV Agents; Arrestins; Benzylamines; beta-Arrestins; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Dose-Response Relationship, Drug; Enzyme Activation; HEK293 Cells; Heterocyclic Compounds; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oligopeptides; Peptidomimetics; Protein Structure, Tertiary; Receptors, CXCR; Receptors, CXCR4; Recombinant Fusion Proteins

2010
Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.
    Blood, 2012, Jan-19, Volume: 119, Issue:3

    Topics: Adult; Aged; Animals; Anti-HIV Agents; Benzylamines; Blotting, Western; Cell Movement; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Cyclams; Cytokines; Drug Combinations; Drug Synergism; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Immunoenzyme Techniques; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Mice, SCID; Mice, Transgenic; Middle Aged; Oligopeptides; Phosphotransferases (Alcohol Group Acceptor); Prognosis; Real-Time Polymerase Chain Reaction; Receptors, CXCR4; Receptors, Lysosphingolipid; RNA, Messenger; Sphingosine; Sphingosine-1-Phosphate Receptors

2012
Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.
    Molecular medicine (Cambridge, Mass.), 2014, Oct-13, Volume: 20

    Topics: Adrenergic Agonists; Animals; Benzylamines; Blood Pressure; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; In Vitro Techniques; Ligands; Male; Mesenteric Arteries; Myocytes, Cardiac; Oligopeptides; Phenylephrine; Rats, Inbred Lew; Receptors, Adrenergic, alpha-1; Receptors, CXCR; Receptors, CXCR4; Shock, Hemorrhagic; Ubiquitin; Vasoconstriction; Ventricular Function, Left

2014
Single-Molecule Imaging Demonstrates Ligand Regulation of the Oligomeric Status of CXCR4 in Living Cells.
    The journal of physical chemistry. B, 2017, 02-23, Volume: 121, Issue:7

    Topics: Benzylamines; Cell Line, Transformed; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; Humans; Ligands; Microscopy, Fluorescence; Oligopeptides; Protein Multimerization; Receptors, CXCR4

2017